Study of Everolimus Added to Combined Hormonal and Radiation Therapy for High Risk Prostate Cancer
Clinical trial NCT01642732 · TERMINATED
Trial details
- NCT number
- NCT01642732
- Sponsor
- University of Michigan Rogel Cancer Center
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-10-01
- Primary completion
- 2014-08-01
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.